425 results on '"Boren, Jan"'
Search Results
2. Synthesis, spectroscopic characterization, DFT and molecular docking of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl) naphthalene-1-sulfonamide derivatives
3. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma
4. Adipocyte PI3K links adipostasis with baseline insulin secretion at fasting through an adipoincretin effect
5. Sulfone-based human liver pyruvate kinase inhibitors – Design, synthesis and in vitro bioactivity
6. Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study
7. Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study
8. ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization
9. Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis
10. High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner
11. The acute effect of different NAD+ precursors included in the combined metabolic activators
12. Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators
13. AdipoR2 recruits protein interactors to promote fatty acid elongation and membrane fluidity
14. Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis
15. Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators
16. Metabolism of Triglyceride-Rich Lipoproteins
17. Abstract 16780: Single Cell Profiles of Human Heart Failure and Myocardial Diseases
18. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study
19. Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
20. Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase
21. Revisiting the role of serine metabolism in hepatic lipogenesis
22. Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose-induced metabolic dysfunction in rats
23. A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease
24. Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma
25. Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
26. Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning
27. Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins
28. Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose-induced metabolic dysfunction in rats
29. Current Status of COVID-19 Therapies and Drug Repositioning Applications
30. A systems biology approach for studying neurodegenerative diseases
31. Classification of clear cell renal cell carcinoma based on PKM alternative splicing
32. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
33. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
34. Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects
35. Integrative Proteo-Transcriptomic Characterization of Advanced Fibrosis in Chronic Liver Disease Across Etiologies
36. Multi-Tissue Network Analysis Reveals the Effect of JNK Inhibition on Dietary Sucrose-Induced Metabolic Dysfunction in Rats
37. Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
38. Cardiac expression of the microsomal triglyceride transport protein protects the heart function during ischemia
39. Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function
40. Localised lipid accumulation detected in infarcted mouse heart tissue using ToF-SIMS
41. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
42. Retraction notice to “Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases” [Life Sci. 314 (2023) 121325]
43. Corrigendum to “Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning” [eBioMedicine, 2022;83:104214]
44. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”
45. Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysis
46. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans
47. Requirement of JNK2 for Scavenger Receptor A: Mediated Foam Cell Formation in Atherogenesis
48. ANGPTL3Downregulation Increases Intracellular Lipids by Reducing Energy Utilization
49. Improving the economics of NASH/NAFLD treatment through the use of systems biology
50. Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.